^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    Stockholm3

    Company:
    A3P Biomedical
    Type:
    Laboratory Developed Test

    Details

    Evidence
    News
    Stockholm3 is a blood test for early detection of aggressive prostate cancer. The test combines protein markers, genetic markers and clinical data in a proprietary algorithm for the purpose of detecting aggressive prostate cancer at an early stage. The result from Stockholm3 is a risk score that indicates the risk of aggressive prostate cancer and a recommendation that describes continued treatment.
    Cancer:
    Prostate Cancer